Muthanna S. Farhan1 , Maadh H. Ahmed1
Unknown Affiliation

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Synthesis, Characterization and Anti-Inflammatory Study of New Heterocyclic Coumarin Derivatives Muthanna S. Farhan1 , Maadh H. Ahmed1
Indian Journal of Forensic Medicine & Toxicology Vol. 15 No. 1 (2021): Indian Journal of Forensic Medicine & Toxicology
Publisher : Institute of Medico-legal Publications Pvt Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37506/ijfmt.v15i1.13755

Abstract

The inflammation is one of the most central processes in animal cells defense versus certain injuries orinfections of microbes. The most essential metabolic precursor for many inflammatory pathways is PGH2(prostaglandin), which catalytic synthesis from the AA (arachidonic acid) by COX enzymes. COX can bedivided in to three isomer COX-1 has important role in many physiological function like hemostasis, plateletaggregation, and protection of gastric mucosa, COX-2 when stimulate cause formation of PGE2 excessively,with other prostaglandin then decrease the pain threshold and nerve ending sensitization, which inducepain, increase permeability of vascular and then enhance the inflammatory associated diseases pathway, andCOX-3 has special characteristic, its higher sensitivity to acetaminophen and present in brain. The NSAIDsare therapeutic agents used for the treatment of inflammation, pain, and fever, they work by decreasing theproduction of prostaglandins due to inhibiting the function of the cyclooxygenase (COX) enzyme, we havetwo types nonselective and selective COX-2 inhibitors. In order to design new agents with no or low sideeffect, the COX-2 selectivity should be increased, this achieved by design molecule structurally similar toapproved selective COX-2 inhibitors. The synthetic compound in this study contain three pharmacophores,a nucleus of coumarin and substituted oxazole moiety, separated by a hydrazonoethyl spacer, which havestructural similarity properties to selective COX-2 inhibitors.